Arming OVs with the ability to produce chemokines, such as chemotactic cytokine CCL5, increases the recruitment of anti-tumor CD8+ T cells and NK cells, which express the receptor for CCL5, CCR5 [110]. Here, CD8A is linked to neoplasm.